Literature DB >> 31206715

Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma.

Salvatore Lorenzo Renne1, Ha Young Woo2, Sarah Allegra1, Noemi Rudini1, Hirohisa Yano3, Matteo Donadon4,5, Luca Viganò4,5, Jun Akiba6, Hye Sun Lee7, Hyungjin Rhee8, Young Nyun Park2, Massimo Roncalli1,5, Luca Di Tommaso1,5.   

Abstract

We investigated the clinical significance of a vascular growth pattern of hepatocellular carcinoma (HCC), the vessels that encapsulate tumor clusters (VETC), previously linked to HCC metastatic dissemination. VETC was assessed in a large multi-institutional cohort of 541 resected HCCs from Italy, Korea and Japan, and matched against a full spectrum of clinical and pathological variables. The VETC phenotype (defined as ≥ 55% tumor area by CD34 immunostaining) was easily reproducible and reliably detectable in whole sections and small-sized tissues of tissue microarray. VETC HCCs represented 18.9% of the whole series, the lowest proportion occurring in the cohort with smallest tumors (8.7%, Japanese series). VETC was significantly associated with several clinical and pathological features such as high alfa-fetoprotein (AFP) level, tumor size greater than 5 cm, poor differentiation, macrotrabecular pattern, less compact pattern, less inflammatory infiltrates, and frequent microvascular invasion. VETC was associated with early recurrence (hazard ratio [HR]: 1.52 [1.06-2.19], P = 0.023), disease-free survival (HR: 1.66 [1.21-2.27], P = 0.002), and overall survival (HR: 2.26 [1.37-3.72], P = 0.001) at multivariable analysis. VETC affected the survival in HCC patients stratified for etiology (hepatitis C virus/hepatitis B virus), vascular invasion, and specific molecular phenotypes (β-catenin/GS+). This distinct vascular pattern was enriched in the recently reported macrotrabecular massive HCC subtype, which was seen in 7.8% (42 of 541) of patients and associated with high AFP levels and poor differentiation.
Conclusion: The VETC pattern was found to be easily detectable in a consistent fraction of HCC and a powerful pathological finding affecting survival. This study suggests that the heterogeneous pattern of angiogenesis is involved in HCC behavior.
© 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2019        PMID: 31206715     DOI: 10.1002/hep.30814

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

1.  Dual angiogenesis and PD-1 blockade in hepatocellular carcinoma.

Authors:  Julien Calderaro
Journal:  Hepatobiliary Surg Nutr       Date:  2020-06       Impact factor: 7.293

Review 2.  Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.

Authors:  Hyungjin Rhee; Haeryoung Kim; Young Nyun Park
Journal:  Liver Cancer       Date:  2020-10-23       Impact factor: 11.740

3.  Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma.

Authors:  Roger Esteban-Fabró; Catherine E Willoughby; Marta Piqué-Gili; Carla Montironi; Jordi Abril-Fornaguera; Judit Peix; Laura Torrens; Agavni Mesropian; Ugne Balaseviciute; Francesc Miró-Mur; Vincenzo Mazzaferro; Roser Pinyol; Josep M Llovet
Journal:  Clin Cancer Res       Date:  2022-06-01       Impact factor: 13.801

4.  Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.

Authors:  Norifumi Iseda; Shinji Itoh; Tomoharu Yoshizumi; Takahiro Tomiyama; Akinari Morinaga; Tomonari Shimagaki; Huanlin Wang; Takeshi Kurihara; Takeo Toshima; Yoshihiro Nagao; Noboru Harada; Yoshinao Oda; Masaki Mori
Journal:  Int J Clin Oncol       Date:  2021-07-12       Impact factor: 3.402

5.  Texture Analysis Based on Gd-EOB-DTPA-Enhanced MRI for Identifying Vessels Encapsulating Tumor Clusters (VETC)-Positive Hepatocellular Carcinoma.

Authors:  Yanfen Fan; Yixing Yu; Ximing Wang; Mengjie Hu; Mingzhan Du; Lingchuan Guo; Shifang Sun; Chunhong Hu
Journal:  J Hepatocell Carcinoma       Date:  2021-05-05

6.  Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.

Authors:  Yanfen Fan; Yixing Yu; Mengjie Hu; Ximing Wang; Mingzhan Du; Lingchuan Guo; Chunhong Hu
Journal:  Br J Radiol       Date:  2021-01-20       Impact factor: 3.039

Review 7.  Integrative Concepts for Liver Surgery.

Authors:  Stefan Heinrich; Felix Watzka; Hauke Lang
Journal:  Visc Med       Date:  2020-09-17

8.  Assessment of Vascular Network Connectivity of Hepatocellular Carcinoma Using Graph-Based Approach.

Authors:  Qiaoyu Liu; Boyu Zhang; Luna Wang; Rencheng Zheng; Jinwei Qiang; He Wang; Fuhua Yan; Ruokun Li
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

Review 9.  Hepatocellular carcinoma: a clinical and pathological overview.

Authors:  Salvatore Lorenzo Renne; Samantha Sarcognato; Diana Sacchi; Maria Guido; Massimo Roncalli; Luigi Terracciano; Luca Di Tommaso
Journal:  Pathologica       Date:  2021-06

10.  Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma.

Authors:  Shuqi Mao; Xi Yu; Yong Yang; Yuying Shan; Joseph Mugaanyi; Shengdong Wu; Caide Lu
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.